Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Cervical Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT05812235
What this trial is testing

Bone Microstructure by Using HR-pQCT After Esophagectomy

Who this might be right for
OsteoporosisSarcopeniaEsophageal Cancer
Nagasaki University 118
Testing effectiveness (Phase 2)Looking for participantsNCT05902988
What this trial is testing

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

Who this might be right for
Advanced Solid TumorHigh Grade Serous Adenocarcinoma of OvarySquamous Non-small-cell Lung Cancer+7 more
Volastra Therapeutics, Inc. 200
Testing effectiveness (Phase 2)Looking for participantsNCT06814496
What this trial is testing

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

Who this might be right for
MelanomaMedullary Thyroid CancerSinonasal Undifferentiated Carcinoma+8 more
University of Arizona 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06611826
What this trial is testing

GEP Combined With Radiotherapy in Non-locally Treatable Recurrent NPC

Who this might be right for
Nasopharynx Cancer
Zhejiang Cancer Hospital 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT06943833
What this trial is testing

Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (IVOLGA)

Who this might be right for
Locally Advanced Cervical Cancer
AstraZeneca 37
Testing effectiveness (Phase 2)Study completedNCT01303328
What this trial is testing

Safety and Efficacy Study of Antiviral Local Application to Treat High Grade Cervical Intraepithelial Lesions (CIN2/3)

Who this might be right for
Uterine Cervical NeoplasiaCervix Intraepithelial Neoplasia
Mithra Pharmaceuticals 200
Testing effectiveness (Phase 2)Study completedNCT00003744
What this trial is testing

Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During Surgery

Who this might be right for
Head and Neck Cancer
Dana-Farber Cancer Institute 16
Not applicableStudy completedNCT01851772
What this trial is testing

Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer

Who this might be right for
Cervical Cancer
Xoft, Inc. 3
Not applicableLooking for participantsNCT06291311
What this trial is testing

Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants

Who this might be right for
HPV InfectionCervical Cancer
University Hospital Tuebingen 50
Testing effectiveness (Phase 2)UnknownNCT01444547
What this trial is testing

A Study on Predictive Value of ERCC1 in Esophageal Cancer Patients Treated With Paclitaxel and Cisplatin

Who this might be right for
Esophageal Cancer
Chinese Academy of Medical Sciences 92
Testing effectiveness (Phase 2)Ended earlyNCT00126607
What this trial is testing

Trastuzumab in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer

Who this might be right for
High-grade Salivary Gland Mucoepidermoid CarcinomaRecurrent Salivary Gland CancerSalivary Gland Acinic Cell Tumor+5 more
National Cancer Institute (NCI) 35
Large-scale testing (Phase 3)Active Not RecruitingNCT05587374
What this trial is testing

Cadonilimab (PD-1/CTLA-4 Bispecific Blockade) and Chemoradiotherapy in Nasopharyngeal Carcinoma (GEMSTONE)

Who this might be right for
Nasopharyngeal CarcinomaNasopharyngeal Cancer
Sun Yat-sen University 490
Testing effectiveness (Phase 2)Study completedNCT06812403
What this trial is testing

Combination COMBO Endoscopy Oropharyngeal Airway With High-Flow Nasal Cannula Oxygenation in Sedated Gastrointestinal Endoscopy for Obese Patients

Who this might be right for
HypoxiaEsophageal CancerGastric Cancer+1 more
Zhejiang University 50
Not applicableEnded earlyNCT00393224
What this trial is testing

Defining the Clinical Utility of EBV Antibody Screening to Identify Individuals Susceptible to Nasopharyngeal Carcinoma (NPC) Within High-Risk, Multiplex NPC Families

Who this might be right for
Nasopharyngeal Neoplasms
National Cancer Institute (NCI) 952
Testing effectiveness (Phase 2)UnknownNCT03925090
What this trial is testing

Phase II Trial of Neoadjuvant and Adjuvant Anti-PD-1 Antibody Toripalimab Combined With CCRT in NPC Patients

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 150
Not applicableNot Yet RecruitingNCT07605312
What this trial is testing

AI-Based Risk Prediction Model for Upper Digestive Tract Cancer

Who this might be right for
Gastric Cancer (GC)Premalignant LesionGastric Intestinal Metaplasia+3 more
National Taiwan University Hospital 10,000
Testing effectiveness (Phase 2)UnknownNCT03910634
What this trial is testing

IMRT With Carboplatin Versus IMRT With Carboplatin and Fluorouracil for Eldly Esophageal Cancer Patients

Who this might be right for
Esophageal CancerRadiotherapy Side Effect
Sun Yat-sen University 264
Not applicableStudy completedNCT03816748
What this trial is testing

The Efficacy of Postoperative Application of HFNC at Acute Phase for Minimally Invasive Esophagectomy Surgery Patients

Who this might be right for
Esophageal Cancer
National Taiwan University Hospital 69
Not applicableStudy completedNCT02850991
What this trial is testing

Different Radiation Dose With Concurrent Chemotherapy for Thoracic Esophageal Carcinoma

Who this might be right for
Esophageal Cancer
Peking University Cancer Hospital & Institute 167
Early research (Phase 1)UnknownNCT03925896
What this trial is testing

Phase I Trial of LMP2 Antigen-specific TCR T-cell Therapy for Recurrent and Metastatic NPC Patients

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 27
Next Page